Cramer Rosenthal Mcglynn LLC cut its holdings in Cooper Companies Inc (NYSE:COO) by 8.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 74,794 shares of the medical device company’s stock after selling 6,865 shares during the period. Cramer Rosenthal Mcglynn LLC owned 0.15% of Cooper Companies worth $16,296,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of COO. Crossmark Global Holdings Inc. acquired a new position in Cooper Companies in the 3rd quarter valued at $339,000. Canada Pension Plan Investment Board acquired a new position in Cooper Companies in the 3rd quarter valued at $163,000. Prudential Financial Inc. raised its holdings in Cooper Companies by 1.8% in the 3rd quarter. Prudential Financial Inc. now owns 69,808 shares of the medical device company’s stock valued at $16,552,000 after acquiring an additional 1,240 shares during the last quarter. CIBC Asset Management Inc raised its holdings in Cooper Companies by 8.6% in the 3rd quarter. CIBC Asset Management Inc now owns 5,101 shares of the medical device company’s stock valued at $1,209,000 after acquiring an additional 404 shares during the last quarter. Finally, New York State Common Retirement Fund raised its holdings in Cooper Companies by 0.5% in the 3rd quarter. New York State Common Retirement Fund now owns 226,107 shares of the medical device company’s stock valued at $53,612,000 after acquiring an additional 1,200 shares during the last quarter. Institutional investors own 98.55% of the company’s stock.
In other news, Director Allan E. Rubenstein sold 500 shares of the business’s stock in a transaction on Wednesday, December 27th. The shares were sold at an average price of $222.00, for a total transaction of $111,000.00. Following the completion of the sale, the director now directly owns 6,590 shares of the company’s stock, valued at approximately $1,462,980. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director A Thomas Bender sold 9,150 shares of the business’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $229.17, for a total transaction of $2,096,905.50. Following the sale, the director now directly owns 11,205 shares of the company’s stock, valued at $2,567,849.85. The disclosure for this sale can be found here. Insiders have sold a total of 104,516 shares of company stock valued at $24,459,155 over the last three months. Corporate insiders own 1.60% of the company’s stock.
COO has been the subject of several analyst reports. Stifel Nicolaus reiterated a “buy” rating and issued a $265.00 price target (down from $275.00) on shares of Cooper Companies in a report on Friday, December 8th. Raymond James Financial reiterated a “buy” rating and issued a $265.00 price target on shares of Cooper Companies in a report on Monday, December 4th. Zacks Investment Research upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $257.00 price target for the company in a report on Tuesday, November 14th. Jefferies Group reiterated a “buy” rating and issued a $285.00 price target on shares of Cooper Companies in a report on Friday, March 9th. Finally, TheStreet downgraded Cooper Companies from a “b” rating to a “c” rating in a report on Thursday, March 8th. Eight investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Cooper Companies currently has a consensus rating of “Hold” and an average target price of $267.50.
Shares of Cooper Companies Inc (NYSE:COO) opened at $236.86 on Wednesday. Cooper Companies Inc has a 12 month low of $192.75 and a 12 month high of $260.26. The stock has a market cap of $11,811.70, a price-to-earnings ratio of 67.87, a PEG ratio of 1.89 and a beta of 0.61. The company has a current ratio of 2.83, a quick ratio of 1.61 and a debt-to-equity ratio of 0.75.
Cooper Companies (NYSE:COO) last announced its quarterly earnings data on Thursday, March 8th. The medical device company reported $2.79 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.51 by $0.28. Cooper Companies had a net margin of 7.83% and a return on equity of 16.90%. The company had revenue of $590.00 million during the quarter, compared to analysts’ expectations of $583.07 million. During the same period in the previous year, the company earned $1.93 EPS. The business’s quarterly revenue was up 18.2% compared to the same quarter last year. sell-side analysts predict that Cooper Companies Inc will post 11.83 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Cramer Rosenthal Mcglynn LLC Cuts Position in Cooper Companies Inc (COO)” was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://ledgergazette.com/2018/03/14/cramer-rosenthal-mcglynn-llc-cuts-position-in-cooper-companies-inc-coo.html.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.